The present study was performed to clarify the relationship between human T cell lymphotropic virus type I (HTLV-I) infection and chronic inflammatory arthropathy. To determine the ability of HTLV-I to infect synovial cells and the effect on synovial cell proliferation, synovial cells were cocultured with the HTLV-I-producing T cell lines (MT-2 or HCT-1). After coculture with HTLV-I-infected T cells, the synovial cells expressed HTLV-I-specific core antigens, and HTLV-I proviral DNA was detected from the synovial cells by polymerase chain reaction. These cocultured synovial cells with HTLV-I-infected T cells proliferated more actively than the synovial cells cocultured with uninfected T cells. This stimulatory effect of HTLV-
Introduction
Human T cell lymphotropic virus type I (HTLV-I) ' is known to be the etiologic agent of adult T cell leukemia/lymphoma (ATLL) ( 1 ) and is also associated with a chronic neurodegenerative syndrome termed HTLV-I-associated myelopathy (HAM) (2) or tropical spastic paraparesis (TSP) (3) . Re-cently, we and other investigators have reported that proliferative synovitis is seen in patients with ATLL (4, 5) and HAM/ TSP (6) . On the other hand, patients with chronic inflammatory arthropathy are shown to be sero-positive for anti-HTLV-I antibodies with high frequency in the southwest of Japan, which is one ofthe endemic area ofHTLV-I (7, 8) . Kitajima et al. (9) detected HTLV-I proviral DNA and viral gene expression in synovial cells from polyarthritic patients with anti-HTLV-I antibodies. More recently, Iwakura et al. ( 10) demonstrated that transgenic mice that carry the HTLV-I genome developed proliferative synovitis, which resembles rheumatoid arthritis. These findings suggest that HTLV-I has tropism for synovial cells and is one of the etiologic agents of chronic arthropathy. But the details of mechanism of the pathological association between arthropathy and HTLV-I remain to be clarified. To resolve this problem, we sought to determine whether synovial cells can be infected with HTLV-I and whether such infection may affect the synovial cell proliferation and the production of cytokines. We demonstrate here that synovial cells cocultivated with an HTLV-I-producing T cell line expressed HTLV-I viral antigens and proviral DNA. Moreover, the HTLV-I-infected synovial cells produce GM-CSF and these cells might trigger active proliferation of synovial cells.
Methods
Preparation of human synovial cells. Synovial tissues were obtained from patients with rheumatoid arthritis (RA) who were underwent arthroscopic synovectomy or corrective surgery. Their seronegativity for anti-HTLV-I antibody was confirmed by Western blot analysis using HTLV-I antigens derived from the MT-2 cell line (Eitest ATL-WB, Eisai Inc., Tokyo, Japan) ( 1) . Synovial cells were obtained by enzymatic digestion as reported elsewhere (12) . In brief, after removing adipose tissue, synovial tissues were washed in HBSS. The synovial membranes were minced aseptically, then dissociated enzymatically with 100 gg/ml collagenase (Sigma Chemical Co., St Louis, MO) and 3.3 mg/ml dispase (Godo Shusei Co., Tokyo, Japan) in HBSS for 30 min at 370C and stirred gently. After Cocultivation ofhuman synovial cells and HTL V-I-infected Tcells.  MT-2 and HCT-I cells were used as the HTLV-I-infected T cell lines. MT-2 was obtained by coculturing peripheral leukemic cells from ATLL patient with normal umbilical cord leukocytes ( 13) , and HCT-l is a T cell line established from cells in the cerebro-spinal fluid of a patient with HAM (14) . HCT-I cells proliferate dependently on interleukin 2 and are positive for CD4 antigeps on the cell surface. Both cell lines contain proviral HTLV-I DNA and produce viral particle. These cells were treated with 100 sg/ml ofmitomycin C for 1 h at 370C (15) . After washing three times with HBSS, they were cultured with an equal number of human synovial cells in RPMI 1640 containing 5% FCS. A total of 5 X I05 ofeach ofthe cells were added to culture dishes (Falcon 3003; Becton Dickinson & Co.), or 1.5 X 104 of each ofthe cells were added to 24-well flat-bottomed culture plates (Coster, Cambridge, MA). This gave the same cell density under both sets ofculture condition. The culture medium was changed every 3-4 d. MOLT4 and CEM cells were used as the uninfected T cell lines. In some experiments, synovial cells were cultured with mitomycin C-treated T cells in a Millicell (Millipore Products Division, Bedford, MA) equipped with the transparent, 0.4-Mm pore membrane. In this system, synovial cells were cultured without contact of T cells, while having the same medium.
Immunostaining. Immunohistochemical staining was performed by the avidin-biotin-immunoperoxidase method as reported elsewhere (16) , and by indirect immunofluoresce. First, the cells were cultured in eight-chamber glass slides (Nunc, Naperville, IL). 1.5 x 104 of cells were incubated in each well for 3 d, then the cells were fixed with cold acetone for 10 min. For immunohistochemical staining, endogenous peroxidase was inactivated by placing the slide into 0.3% H202 in HBSS for 10 min at room temperature. The cells were then incubated with a diluted solution of the primary anti-human monoclonal antibodies; anti-CD3, anti-Leu-M3, and anti-CD29 (reactive with the VLA-,B chain) (Coulter Immunology), anti-human Von Willebrand factor, and Ginl4 (monoclonal mouse antibody reactive with the HTLV-I core proteins p19 and p28) (Fujirebio, Inc., Tokyo, Japan) (17) , and using the Histofine staining reagents kit (Nichirei Co., Tokyo, Japan).
The sections were treated with biotinylated goat anti-mouse IgG for 12 min. After being washed, the treated sctions were incubated with streptavidin-peroxidase conjugates, after which they were incubated in 0.5 mg/ml of diaminobenzidine (Sigma Chemical Co.) prepared in 5 mM Tris buffer solution, pH 7.6, containing 0.03% H202, then stained with hematoxylin. The control sections were treated routinely with mouse IgG (Coulter Immunology) instead of a specific monoclonal antibody. Furthermore, the cells were analyzed by a double immunofluorescence as described in detail previously (18) . Briefly, the cells were exposed to a fluorescein isothiocyanate-conjugated polyclonal rabbit anti-GM-CSF (anti-human GM-CSF; Polyvalent, Endogen, MA) and a rhodamine-conjugated GIN 14 monoclonal antibody for 1 h at 4°C. Rabbit antibody against human alpha-I -fetoprotein (Dako Corp., Carpinteria, CA) and mouse IgG were used for control antibodies. After each section was washed, positive cells were determined by a fluorescence microscopy (Micro Systems, Zeiss LSM, Germany).
Isolation ofDNA. High-molecular weight DNAs of synovial cells or T cells were isolated by the method described previously (19) with some modification. Briefly, cells were lysed and digested by 0.5% SDS and 0.5 mg/ml of proteinase K, followed by phenol and chloroform. The extracted DNA was precipitated with ethanol and finally dialyzed against TE buffer.
Detection of HTL V-I proviral DNA. To detect the pX region of HTLV-I proviral DNA in synovial cells, PCR was used as previously described (20) Norwalk, CT) in a total volume of 50 ,u. Sample DNA was amplified 30 cycles using the outer primers. Then, I/1o of these PCR products were subjected to 30 cycles ofamplification using inner pX primers. In each cycle ofPCR, the mixture was denatured at 940C for 2 min (3 min for first cycle), annealed at 60'C for 2 min, and then extended at 720C for 2 min on a DNA thermal cycler (PC-500; Astec, Fukuoka, Japan).
10 ;d ofeach final PCR product was loaded on a composite gel containing 1% NuSieve/ 1% Seaken agaroses (FMC Co., Rockland, ME), electrophorated, and visualized with ethidium bromide fluorostaining. Finally, the DNA in the agarose gel was transferred to a Zeta-Probe nylon membrane (Bio-Rad Laboratories, Richmond, CA) and hybridized with a 32P-labeled genomic HTLV-I pX probe (base pairs 7421-7459).
Synovial cell-proliferation assay. Synovial cells ( 1.5 x 104/well) were cultured with or without mitomycin C-treated HTLV-I-infected or uninfected T TCA-insoluble material was harvested in 500 ,d of 5% SDS. The radioactivity of each sample was determined with a liquid scintillation counter. The results were expressed as the mean counts per min (cpm) or a stimulation index (SI), where: SI = mean cpm of synovial cells cocultured with T cells/mean cpm ofsynovial cells uncocultured. Furthermore, the number of viable synovial cells was also counted by trypan blue dye exclusion.
Cytokine measurement. The cells, 1.5 X 104/well, were incubated in a 24-well plate with the medium supplemented with 5% FCS. After 5 d the supernatants were collected and used for assay. IL-la, IL-Ijl, TNF-a, and GM-CSF were measured by an immunoenzymetric assay. Briefly, plates precoated with monoclonal antibody to each cytokine were incubated with samples, incubated further with polyclonal rabbit anticytokine antibody, and then reacted with goat anti-rabbit Ig conjugated to horseradish peroxidase. Between each step excess reactants were removed by washing three times with 0.01 M phosphate buffer (pH 7.4) containing 1% bovine serum albumin. Addition of enzyme substrate produced a chromogenic product whose absorbance was measured at 490 nm. The sensitivity ofthe cytokine determination was as follows: IL-Ia, 10 pg/ml; IL-Il, 20 pg/ml; TNF-a, 20 pg/ml; and GM-CSF, 100 pg/ml.
Statistical analysis. The statistical significance of any difference was calculated using student's t test. 14 despite the careful observation of > 10,000 cells (Fig. 1 B) . These GIN 14-positive cells were all adherent and fibroblastic, indicating synovial cells expressed HTLV-I viral antigens. Detection ofHTL V-I proviral DNA. We also sought to determine whether the HTLV-I cDNA was integrated in the synovial cells after coculture with MT-2 cells. DNA samples were isolated from the fifth-passage synovial cells that had been cocultured with MT-2 cells. We confirmed that MT-2 cell contamination in sample synovial cells was < 1:10,000 by immunohistochemical and immunofluorescent staining with anti-CD3 antibody. We initially attempted to detect HTLV-I cDNA by Southern blot analysis. Although a positive signal for MT-2 DNA was detected, we could not obtain any signal from the synovial cells cocultured with MT-2 cells. Therefore, the PCR method was used. To determine the sensitivity of the PCR, serial 10-fold dilutions of MT-2 DNA ( 1.0 to 108 sug) were amplified. With our nested PCR system, specific bands for the HTLV-I pX region were detected from MT-2 DNA up to a o0-6 dilution (1 pg of MT-2 DNA). The size of the main target PCR product was 120 bp (pX8-pX9), but bands of 159 bp (pXl-pX9), 164 bp (pX8-pX2), and 203 bp (pXl-pX2)
were also detected as the subproducts. DNA from CEM cells 1A and the synovial cells of HTLV-I-negative patients was uniformly negative, whereas DNA from synovial cells cocultured with MT-2 cells revealed positive bands. DNAs from three different synovial cells and their respective cocultured cells were amplified (Fig. 3) . Although the DNAs from uncocultured synovial cells uniformly revealed negative signals (Fig. 3, lanes 3 , 5, and 7), samples from cocultured synovial cells indicated positive bands (lanes 4, 6, and 8). A 10-fold dilution study was also performed, and it revealed that HTLV-I pX bands were detected at dilutions of up to l0-3 or 10-'. A representative example is shown in Fig. 4 . Since MT-2 cell contamination was < 1:10,000 synovial cells, synovial cell DNA contained < l0-4 ,ug of MT-2 DNA and the contamination band should only be detected at a dilution of < 10-2. Since positive signals were detected from the synovial cells at dilutions of i0' or 10', these strong signals were apparently derived from HTLV-I-infected synovial cells rather than MT-2 cells. In fact, when a sample of l0-4 jig of MT-2 DNA was added to 1 ug of DNA from HTLV-I-uninfected synovial cells, the positive signal for HTLV-I was only detected up to a dilution of 10-2 (data not shown). These results were also confirmed by Southern blot analysis of PCR products.
Proliferation ofsynovial cells. To investigate the relation of synovial cell proliferation and HTLV-I infection, proliferative response of synovial cells was examined by cocultivation with HTLV-I-producing T cells (MT-2 and HCT-I), and compared MT-2 cells per well (data not shown), so subsequent coculture experiments were done with the same number of cells. Fig. 5 shows a representative kinetic study as indicated by stimulation index of [3HIthymidine incorporation. The proliferative response ofsynovial cells reached a peak at culture day 5 (stimulation index, 5.5±0.9). Because we did not supply fresh medium and did not passage the cells during culture, the diminished proliferation of synovial cells at the end of the experiments may be due to either lack of fresh medium or contact inhibition. Synovial cells were also stimulated to proliferate when cocultured with HCT-1 cells, whereas HTLV-I-uninfected T cells (CEM and MOLT4) did not stimulate the proliferation of synovial cells (Figs. 5 and 6 ). Next, we investigated cytokine release by HTLV-I-infected T cell. As shown in Table I S.'. (Fig. 8) . Synovial cells also proliferated strongly from the second to eighth passages after coculture with MT-2 cells. After coculture with MT-2 cells, the number of synovial cells in the third passage was increased significantly when compared with cultures of control synovial cells alone (Table II, exp. 3). We also investigated the morphology of synovial cells after coculture with or without MT-2 cells. On day 10, synovial cells that had been cultured without a medium change had a round or oval shape, 1962 Sakai et al. and some of them were detached from the culture dish. In contrast, synovial cells cocultured with MT-2 cells grew to confluence and overgrew in some parts of the culture wells. These cocultured synovial cells were spindle-like and adherent to the culture dishes (Fig. 9) . HTLV-I-infected synovial cells were detected by immunostaining with GIN 14 after each passage. It was found that proliferative stimulation ofsynovial cells cocultured with MT-2 cells persisted through several passages, suggesting that not transient cell-to-cell contact but HTLV-I infection of synovial cells caused their proliferation. GM-CSF production by HTLV-I-infected synovial cells. Some of the synovial cells became infected by HTLV-I when cocultured with HTLV-I-producing T cells. Therefore, we next investigated the functioning of such HTLV-I-infected synovial cells. Initially, we measured the cytokines in the culture supernatants ofHTLV-I-infected synovial cells by immunoenzymetric assays. When synovial cells were cocultured with MT-2 cells, the medium contained a considerable amount of GM-CSF, although the medium of unstimulated synovial cell cultures did not. As for IL-la, IL-1If, or TNF-a, none of these cytokines was detected in the medium of either cocultured or uncocultured synovial cells. The same results were obtained after one or two passages (Table I) .
--------------------------------------------------------
Cultured synovial cells were stained by the double-immunofluorescence method. Fig. 2 shows that synovial cells reacting transactivates various cellular genes (21, 22) . By PCR, the HTLV-I pX genome was also detected in the sample DNA. The efficiency of infection by this method was relatively low, and 1:500-1000 synovial cells were infected with HTLV-I in the immunohistochemical study. This level of infection coresponded to the resufts of the PCR, as indicated by the 10-fold dilution study, which showed a 102-to 103-fold difference from MT-2 DNA. Thus, it was reasonable that HTLV-I signal could not be detected by direct Southern blot analysis.
To the best ofour knowledge, this is the first demonstration that HTLV-I can infect human synovial cells in vitro. HTLV-I has tropism to CD4+ lymphocyte, but nonlymphoid cells such as vascular endothelial cells (23, 24) , fibroblasts (25) , human lung cell line, and human uterine cervical carcinoma cell line (26) were reported to be infected by HTLV-I when these cells are cocultivated in vitro with irradiated HTLV-I-producing T cells. Recently HTLV-I viral antigens and tax I/rexI messenger RNA were detected in the fresh synovial tissues and cultured synovial cells from patients with HTLV-I-associated chronic inflammatory arthropathy (9) . This finding supports strongly our results that HTLV-I can be transmitted to synovial cells from the infected T cells and the integrated HTLV-I genes can be transcribed and expressed.
HTLV-I-transformed T cells have been reported to produce a multitude of cytokines, including IL-la (27), IL-2 (28, 29), IL-3 (27), IL-6 (30), interferon-y (8), and transforming growth factor ,3 (31 ) . These cytokines may affect the proliferation of synovial cells. In fact, synovial cells cocultured using Millicell proliferated more actively than the control synovial cells. This is probably due to the effect of strong growth factors such as IL-l a and TNF-a (32, 33) , which were detected in the supernatant from mitomycin C-treated HTLV-I-producing T cell line. However, the proliferative response of synovial cells cocultured in the Millicell was significantly lower than that seen in standard cocultures. On the other hand, synovial cells cocultured with HTLV-I-uninfected T cells showed no significant differences in proliferation between standard cocultures and control cultures, suggesting that cell-to-cell attachment alone was not sufficient to enhance the proliferation of synovial cells and that contact with HTLV-I-infected T cells was much more important. It is known that HTLV-I genome transmission occurs only through cell-to-cell contact, and not via free materials (34) . Therefore, the active proliferation ofsynovial cells may have been related to HTLV-I infection. To confirm our speculation that HTLV-I infection of synovial cells caused their active proliferation, the persistence ofthis proliferation was examined. Synovial cells showed active proliferation and morphological changes even after several passages. We excluded the effects of mitomycin C-treated HTLV-I-infected T cells and their products in this experiment, therefore, it appears that HTLV-I infection ofsynovial cells may have some roles in their enhanced proliferation.
The HTLV-I gene product, Tax trans-regulatory protein, is encoded in the pX region ofthe HTLV-I provirus and is trans- lated from the doubly spliced tax/rex transcript (35 ). Tax protein increases the transcription of viral and cellular genes through at least two host transcription factor passways. One is the cAMP-responsive element binding protein (CREB) and activating transcription factor (ATF) family of DNA-binding proteins, and the other is the pleiotropic transcription factor NF-kB, which activates transcription of a variety of cellular and heterologous viral promoters that contain NF-kB enhancer elements (36) . These include the promoters ofthe IL-2, IL-2Ra, long terminal repeat of HIV-I.
Transcription of GM-CSF is regulated by tax protein in HTLV-I-infected T cells (37) . Expression of GM-CSF gene is induced through the action of specific cellular transcription factors that can interact with tax protein (38, 39) . Synovial fibroblasts may potentially express GM-CSF when stimulated by IL-1 or TNF-a (40) as well as lung fibroblasts, monocytes, and endothelial cells (41, 42), but we only detected GM-CSF in the HTLV-I-infected synovial cells by double-immunofluorescence staining. This finding may suggest the possibility that tax protein might operate the transcription ofGM-CSF in synovial fibroblasts the same way as in HTLV-I-infected T cells.
Rheumatoid synovitis is histologically characterized by mononuclear cell infiltration, neovascularization, and synovial cell proliferation. The present study demonstrated that HTLV-I infection of synovial cells caused their proliferation in vitro, however, the mechanism ofthis increased capacity ofthe proliferation is unknown. The role of GM-CSF is reported to increase the expression of HLA class II molecules on monocytes (43) . The expression of HTLV-I proteins in synovial cells, which is related to GM-CSF production, might have some effects on activation or proliferation of synovial cells. Therefore, HTLV-I infection of synovial cells could be involved in the pathogenesis of chronic inflammatory arthropathy in a subset of patients.
